ProText Mobility, Inc. (TXTM)

OTCMKTS · Delayed Price · Currency is USD
0.0051
+0.0006 (13.33%)
Jun 17, 2025, 3:59 PM EDT
410.00%
Market Cap 44.84M
Revenue n/a
Net Income n/a
Shares Out 8.79B
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,926,777
Average Volume 45,118,376
Open 0.0046
Previous Close 0.0045
Day's Range 0.0043 - 0.0053
52-Week Range 0.0001 - 0.0053
Beta n/a
RSI 82.32
Earnings Date n/a

About ProText Mobility

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Roger Baylis-Duffield
Country United States
Stock Exchange OTCMKTS
Ticker Symbol TXTM
Full Company Profile

News

PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND

Boca Raton, Florida, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC PINK: TXTM) is pleased to announce it has executed a Letter of Intent to acquire 100% ownership of a premier vodka Br...

3 years ago - GlobeNewsWire